Treatment of Fecal Incontinence Using Allogenic-Adipose-derived Mesenchymal Stem Cells: A Prospective, Dose Escalation, Randomized, Placebo-controlled, Parallel-group, Single-blind, Single-center Pilot Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
* Purpose: The investigators aimed to investigate the safety and efficacy in the treatment of fecal incontinence by injection of ALLO-ASC into the anal sphincter. * Method 1. Safety test of allogenic ASCs injection 2. Efficacy test of allogenic ASCs injection
Epistemonikos ID: 24e13fc4048a00a20c9d39fbb1f3658999ec7327
First added on: May 12, 2024